Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Meir, Wetzler"'
Autor:
Pankit Vachhani, Sarah Shin, Jeffrey Baron, James E. Thompson, Meir Wetzler, Elizabeth A. Griffiths, Evelena P. Ontiveros, Edward J. Spangenthal, Eunice S. Wang
Publikováno v:
Leukemia Research Reports, Vol 7, Iss C, Pp 36-39 (2017)
Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective agent used
Externí odkaz:
https://doaj.org/article/da86d6d171a64614a5a14fce5058cf65
Autor:
Eunice S. Wang, Charles P. Hart, Meir Wetzler, Megan K. Johnson, Rodrigo Vargas, Yung-Chun Hsu, Deepika Lal, Scott Portwood
PDF file - 120K, Supplemental Figure 5. Effects of hypoxia and drug treatment on ROS generation by AML cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e06cc0554357d7744792b84fd3628f8
https://doi.org/10.1158/1078-0432.22448085
https://doi.org/10.1158/1078-0432.22448085
Autor:
Eunice S. Wang, Gerald J. Fetterly, Meir Wetzler, Joshua Prey, Michael Murphy, Terry J. Mashtare, Lili Tian, Mei-Hui Lin, Amanda M. Perez, Joseph Marinaro, Kellie Demock, Jennifer A. Park, Deepika Lal
Supplementary Figure Legends from Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9a06790ee196dc54350c1040fadee
https://doi.org/10.1158/1535-7163.22485170
https://doi.org/10.1158/1535-7163.22485170
Autor:
Eunice S. Wang, Gerald J. Fetterly, Meir Wetzler, Joshua Prey, Michael Murphy, Terry J. Mashtare, Lili Tian, Mei-Hui Lin, Amanda M. Perez, Joseph Marinaro, Kellie Demock, Jennifer A. Park, Deepika Lal
Supplementary Figures 7-8 from Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b94975dc1ef4269e1ab5391b2fc2bf7
https://doi.org/10.1158/1535-7163.22485164.v1
https://doi.org/10.1158/1535-7163.22485164.v1
Autor:
Eunice S. Wang, Charles P. Hart, Meir Wetzler, Megan K. Johnson, Rodrigo Vargas, Yung-Chun Hsu, Deepika Lal, Scott Portwood
PDF file - 74K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c545079fa47d03864c5ab5324fa8f11b
https://doi.org/10.1158/1078-0432.22448082
https://doi.org/10.1158/1078-0432.22448082
Autor:
Eunice S. Wang, Charles P. Hart, Meir Wetzler, Megan K. Johnson, Rodrigo Vargas, Yung-Chun Hsu, Deepika Lal, Scott Portwood
Purpose: Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm. Recent evidence has shown the bone marrow microenvironment in patients with AML to be intrinsically hypoxic. Adaptive cellular responses by leukemia cells to survive under l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3140e730bce557ff72d4036c8df4797d
https://doi.org/10.1158/1078-0432.c.6521304.v1
https://doi.org/10.1158/1078-0432.c.6521304.v1
Autor:
Eunice S. Wang, Gerald J. Fetterly, Meir Wetzler, Joshua Prey, Michael Murphy, Terry J. Mashtare, Lili Tian, Mei-Hui Lin, Amanda M. Perez, Joseph Marinaro, Kellie Demock, Jennifer A. Park, Deepika Lal
We examined whether potent vascular endothelial growth factor (VEGF) blockade mediated by aflibercept, a decoy VEGF receptor (VEGFR) 1/2 moiety with stronger affinity for VEGF than bevacizumab, resulted in antileukemia effects and enhanced the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c5bc53d18b818b74898fc071fecf2a
https://doi.org/10.1158/1535-7163.c.6531806
https://doi.org/10.1158/1535-7163.c.6531806
Autor:
Eunice S. Wang, Gerald J. Fetterly, Meir Wetzler, Joshua Prey, Michael Murphy, Terry J. Mashtare, Lili Tian, Mei-Hui Lin, Amanda M. Perez, Joseph Marinaro, Kellie Demock, Jennifer A. Park, Deepika Lal
Supplementary Tables 1-3 from Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67aa8fe3c1b71be05d0416092c6cb103
https://doi.org/10.1158/1535-7163.22485158
https://doi.org/10.1158/1535-7163.22485158
Autor:
Eunice S. Wang, Gerald J. Fetterly, Meir Wetzler, Joshua Prey, Michael Murphy, Terry J. Mashtare, Lili Tian, Mei-Hui Lin, Amanda M. Perez, Joseph Marinaro, Kellie Demock, Jennifer A. Park, Deepika Lal
Supplementary Methods and References from Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e73c806839e0a534c08cbe04a9e850b
https://doi.org/10.1158/1535-7163.22485161
https://doi.org/10.1158/1535-7163.22485161
Autor:
Eunice S. Wang, Charles P. Hart, Meir Wetzler, Megan K. Johnson, Rodrigo Vargas, Yung-Chun Hsu, Deepika Lal, Scott Portwood
PDF file - 66K, Supplemental Table 1. Cell cycle analysis of AML cells treated with TH-302. AML cells were treated with vehicle (PBS) or TH- 302 at the indicated concentrations for 24 hours under hypoxic (1% O2) or normoxic (21% O2) conditions in tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c51e52ae83c18c7b8bf08abd07b2c0f
https://doi.org/10.1158/1078-0432.22448079.v1
https://doi.org/10.1158/1078-0432.22448079.v1